tronarcade| China's e-commerce dominates South Korea's overseas shopping consumption: China surpassed the United States for the first time, reaching 17.4 billion yuan

Date: 4个月前 (05-26)View: 69Comments: 0

News summary

South Korea's Haitao Markettronarcade, China has surpassed the United States for the first time and become the largest consumption destination, with transaction volume increasing by 121 year-on-year in 2023tronarcade.2%。

Newsletter text

Chinese e-commerce has captured the South Korean market and led a new trend in overseas shopping

tronarcade| China's e-commerce dominates South Korea's overseas shopping consumption: China surpassed the United States for the first time, reaching 17.4 billion yuan

With the rapid expansion of Chinese e-commerce in the international market, South Korean consumers 'enthusiasm for overseas shopping of Chinese goods continues to heat up. According to the latest data from the Korea Statistics Office, the consumption of Chinese goods from South Korea's overseas shopping industry soared to 3.2873 trillion won (about 17.4 billion yuan) in 2023, a year-on-year increase of more than doubled to 121.2%. This significant growth marks the first time that China has surpassed the United States and ranked first in South Korea's overseas shopping market. Specific to consumer categories, clothing, medical care, beverages, food, and daily and automotive supplies rank at the top of the hot-selling list. These categories reflect the diversified needs of Korean consumers for Chinese products. The analysis believes that Chinese e-commerce has effectively improved the purchasing experience of Korean consumers by optimizing the distribution system, and it is expected that there will be potential for further expansion in the scale of China's overseas shopping in the future.

Tags:

Prev: uplanddapp| Leybold High-Tech: The new glass packaging carrier board product co-developed involves TGV technology
Next: baccaratpink| CITIC Construction Investment: The clinical trial results of domestic innovative pharmaceutical companies at the 2024 ASCO Conference are outstanding, and oncology drugs show BIC potential

Related articlesNo more
︿